Key Points- The Biden administration unveiled the first 10 prescription drugs that will be subject to price negotiations between manufacturers and Medicare.- The announcement kicks off a controversial process under the Inflation Reduction Act that aims to make costly medications more affordable for older Americans. – The list includes Bristol-Myers Squibb’s blood thinner Eliquis, Johnson […]
